An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR
Clinical trial NCT07097701 · RECRUITING
Trial details
- NCT number
- NCT07097701
- Sponsor
- Lupin Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2027-01-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.